Literature DB >> 6208963

Incidence and prognosis of N4 node involvement in gastric cancer.

M R Keighley, J Moore, C Roginski, J Powell, H Thompson.   

Abstract

We have undertaken a prospective study of the frequency and prognosis associated with N4 node metastases in gastric cancer in 136 patients referred for surgical treatment between 1976 and 1983. N4 node metastases (pre-aortic or hepatic hilar nodes) were present in 20 of 31 patients who had a laparotomy without resection (64 per cent), in 2 of 8 patients who had a 'palliative' resection in the presence of distant metastases (25 per cent) and, in 19 of 85 patients who had a 'curative' resection (22 per cent). The median survival in patients having a 'curative' resection with N4 nodes was 4.5 months which was only marginally longer than in patients having a 'palliative' resection (median survival 3 months). In view of these findings and since immediate imprint cytology can be used to detect nodal metastases at operation, involvement of N4 nodes might be a contra-indication to extensive gastric resection in non-obstructing gastric cancer.

Entities:  

Mesh:

Year:  1984        PMID: 6208963     DOI: 10.1002/bjs.1800711121

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A).

Authors:  Yukinori Kurokawa; Taro Shibata; Mitsuru Sasako; Takeshi Sano; Akira Tsuburaya; Yoshiaki Iwasaki; Haruhiko Fukuda
Journal:  Gastric Cancer       Date:  2013-09-03       Impact factor: 7.370

2.  Pathological response measured using virtual microscopic slides for gastric cancer patients who underwent neoadjuvant chemotherapy.

Authors:  Sadayuki Kawai; Tadakazu Shimoda; Takashi Nakajima; Masanori Terashima; Katsuhiro Omae; Nozomu Machida; Hirofumi Yasui
Journal:  World J Gastroenterol       Date:  2019-09-21       Impact factor: 5.742

3.  Disease-free survival for 6 years and 4 months after dissection of recurrent abdominal paraaortic nodes (no. 16) in gastric cancer: report of a case.

Authors:  A Nashimoto; J Sasaki; M Sano; O Tanaka; M Tsutsui; Y Tsuchiya; H Makino
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial.

Authors:  T Haugstvedt; A Viste; G E Eide; O Söreide
Journal:  World J Surg       Date:  1989 Sep-Oct       Impact factor: 3.352

5.  Surgical results of performing R4 gastrectomy for gastric cancer located in the upper third of the stomach.

Authors:  Y Yonemura; M Segawa; H Matsumoto; K Tsugawa; I Ninomiya; L Fonseca; T Fujimura; K Sugiyama; K Miwa; I Miyazaki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Number and size of perigastric lymph nodes in human adults without gastric cancer.

Authors:  F Borchard; P Betz
Journal:  Surg Radiol Anat       Date:  1991       Impact factor: 1.246

7.  Questionnaire survey regarding the current status of super-extended lymph node dissection in Japan.

Authors:  Shinji Morita; Takeo Fukagawa; Hisataka Fujiwara; Hitoshi Katai
Journal:  World J Gastrointest Oncol       Date:  2016-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.